Increased Frequency of Th17 Cells in Children With Mycoplasma pneumoniae Pneumonia

Journal of Clinical Laboratory Analysis

Volumn 30, Issue 6, 2016, Pages 1214-1219

  Wang, Xiaowei ^a   Chen, Xiaojun ^a   Tang, Heng ^a   Zhu, Jifeng ^a   Zhou, Sha ^a   Xu, Zhipeng ^a   Liu, Feng ^a   Su, Chuan ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

children; Mycoplasma Pneumoniae; respiratory infection; Th17 cells

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; CD4 LYMPHOCYTE PERCENTAGE; CHILD; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MYCOPLASMA PNEUMONIA; TH17 CELL; CD4+ T LYMPHOCYTE; INFANT; MYCOPLASMA PNEUMONIAE; NONPARAMETRIC TEST; PATHOGENICITY; PATHOLOGY; PRESCHOOL CHILD;

CD4-POSITIVE T-LYMPHOCYTES; CHILD, PRESCHOOL; FEMALE; FLOW CYTOMETRY; HUMANS; INFANT; MALE; MYCOPLASMA PNEUMONIAE; PNEUMONIA, MYCOPLASMA; STATISTICS, NONPARAMETRIC; TH17 CELLS;

EID: 84994153117     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.22005     Document Type: Article

References (33)

1. Jain S, Self WH, Wunderink RG, et al. Community-Acquired Pneumonia Requiring Hospitalization among US Adults. N Engl J Med 2015;373:415–427.
2. Jain S, Williams DJ, Arnold SR, et al. Community-acquired pneumonia requiring hospitalization among US Children. N Engl J Med 2015;372:835–845.
3. Atkinson TP, Balish MF, Waites KB. Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections. FEMS Microbiol Rev 2008;32:956–973.
4. Michelow IC, Olsen K, Lozano J, et al. Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatrics 2004;113:701–707.
5. Baer G, Engelcke G, Abele-Horn M, Schaad UB, Heininger U. Role of Chlamydia pneumoniae and Mycoplasma pneumoniae as causative agents of community-acquired pneumonia in hospitalised children and adolescents. Eur J Clin Microbiol Infect Dis 2003;22:742–745.
6. Narita M. Pathogenesis of extrapulmonary manifestations of Mycoplasma pneumoniae infection with special reference to pneumonia. J Infect Chemother 2010;16:162–169.
7. Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev 2004;17:697–728, table of contents.
8. Fernald GW, Collier AM, Clyde WA Jr. Respiratory infections due to Mycoplasma pneumoniae in infants and children. Pediatrics 1975;55:327–335.
9. Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 cells. Annu Rev Immunol 2009;27:485–517.
10. Stark MA, Huo Y, Burcin TL, Morris MA, Olson TS, Ley K. Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity 2005;22:285–294.
11. Sherlock JP, Joyce-Shaikh B, Turner SP, et al. IL-23 induces spondyloarthropathy by acting on ROR-gammat+ CD3+ CD4-CD8- entheseal resident T cells. Nat Med 2012;18:1069–1076.
12. Milner JD, Holland SM. The cup runneth over: Lessons from the ever-expanding pool of primary immunodeficiency diseases. Nat Rev Immunol 2013;13:635–648.
13. Michelow IC, Katz K, McCracken GH, Hardy RD. Systemic cytokine profile in children with community-acquired pneumonia. Pediatr Pulmonol 2007;42:640–645.
14. Shao L, Cong Z, Li X, Zou H, Cao L, Guo Y. Changes in levels of IL-9, IL-17, IFN-gamma, dendritic cell numbers and TLR expression in peripheral blood in asthmatic children with Mycoplasma pneumoniae infection. Int J Clin Exp Pathol 2015;8:5263–5272.
15. Kurata S, Osaki T, Yonezawa H, Arae K, Taguchi H, Kamiya S. Role IL-17A and IL-10 in the antigen induced inflammation model by Mycoplasma pneumoniae. BMC Microbiol 2014;14:156.
16. Mangan PR, Harrington LE, O'Quinn DB, et al. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 2006;441:231–234.
17. Infante-Duarte C, Horton HF, Byrne MC, Kamradt T. Microbial lipopeptides induce the production of IL-17 in Th cells. J Immunol 2000;165:6107–6115.
18. Ye P, Rodriguez FH, Kanaly S, et al. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med 2001;194:519–527.
19. Chung DR, Kasper DL, Panzo RJ, et al. CD4+ T cells mediate abscess formation in intra-abdominal sepsis by an IL-17-dependent mechanism. J Immunol 2003;170:1958–1963.
20. Khader SA, Bell GK, Pearl JE, et al. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol 2007;8:369–377.
21. Rudner XL, Happel KI, Young EA, Shellito JE. Interleukin-23 (IL-23)-IL-17 cytokine axis in murine Pneumocystis carinii infection. Infect Immun 2007;75:3055–3061.
22. Huang W, Na L, Fidel PL, Schwarzenberger P. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis 2004;190:624–631.
23. Schwarzenberger P, La Russa V, Miller A, et al. IL-17 stimulates granulopoiesis in mice: Use of an alternate, novel gene therapy-derived method for in vivo evaluation of cytokines. J Immunol 1998;161:6383–6389.
24. McAleer JP, Kolls JK. Mechanisms controlling Th17 cytokine expression and host defense. J Leukoc Biol 2011;90:263–270.
25. Eid RE, Rao DA, Zhou J, et al. Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells. Circulation 2009;119:1424–1432.
26. Rong G, Zhou Y, Xiong Y, et al. Imbalance between T helper type 17 and T regulatory cells in patients with primary biliary cirrhosis: The serum cytokine profile and peripheral cell population. Clin Exp Immunol 2009;156:217–225.
27. Komiyama Y, Nakae S, Matsuki T, et al. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol 2006;177:566–573.
28. Nakae S, Nambu A, Sudo K, Iwakura Y. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol 2003;171:6173–6177.
29. Bending D, De la Pena H, Veldhoen M, et al. Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice. J Clin Invest 2009;119:565–572.
30. Lee YK, Turner H, Maynard CL, et al. Late developmental plasticity in the T helper 17 lineage. Immunity 2009;30:92–107.
31. Shi G, Cox CA, Vistica BP, Tan C, Wawrousek EF, Gery I. Phenotype switching by inflammation-inducing polarized Th17 cells, but not by Th1 cells. J Immunol 2008;181:7205–7213.
32. Zhou L, Chong MMW, Littman DR. Plasticity of CD4+ T Cell lineage differentiation. Immunity 2009;30:646–655.
33. Duhen T, Geiger R, Jarrossay D, Lanzavecchia A, Sallusto F. Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat Immunol 2009;10:857–863.